Get started
Author

Sonja Postma

Observed names: S Postma, S. Postma, S.R. Postma, Sonja R. Postma
OpenAlex ID: A5111967896
Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention
2016 · Vincent Roolvink, Borja Ibáñez, et al. · Journal of the American College of Cardiology · 209
Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial)
2019 · Giuseppe De Luca, Sander A. Damen, et al. · EuroIntervention · 184
A comparison between the Plateletworks™-assay and light transmittance aggregometry for monitoring the inhibitory effects of clopidogrel
2008 · Jochem W. van Werkum, Marjolein Kleibeuker, et al. · International Journal of Cardiology · 54
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and complex or multivessel coronary disease (TCW): an international, multicentre, prospective, open-label, non-inferiority, randomised controlled trial
2024 · Elvin Kedhi, Renicus S Hermanides, et al. · The Lancet · 47
PDF
Pharmacokinetics, pharmacodynamics, and tolerability of subcutaneous administration of a novel glycoprotein IIb/IIIa inhibitor, RUC-4, in patients with ST-segment elevation myocardial infarction
2021 · Willem L. Bor, Kai L. Zheng, et al. · EuroIntervention · 42
Prehospital treatment with zalunfiban (RUC-4) in patients with ST‐ elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial
2022 · Sem A.O.F. Rikken, Abi Selvarajah, et al. · American Heart Journal · 29
PDF
Prehospital triage in the ambulance reduces infarct size and improves clinical outcome
2011 · Sonja Postma, Jan-Henk E. Dambrink, et al. · American Heart Journal · 26
Predictors and outcome of grade 3 ischemia in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
2011 · Sonja Postma, Ton Heestermans, et al. · Journal of Electrocardiology · 22
Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial
2021 · M. Verdoia, H. Suryapranata, et al. · Journal of Thrombosis and Thrombolysis · 20
The influence of residential distance on time to treatment in ST-elevation myocardial infarction patients
2014 · S. Postma, J. H. E. Dambrink, et al. · Netherlands Heart Journal · 18
PDF
An Observational Study on the Effects of Nadroparin-Based and Citrate-Based Continuous Venovenous Hemofiltration on Calcium Metabolism
2007 · Peter H.J. van der Voort, Sonja R. Postma, et al. · Blood Purification · 17
Safety of Citrate Based Hemofiltration in Critically Ill Patients at High Risk for Bleeding: A Comparison with Nadroparin
2006 · P.H.J. Van Der Voort, S.R. Postma, et al. · The International Journal of Artificial Organs · 15
Field triage in the ambulance versus referral via non-percutaneous coronary intervention centre in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A systematic review
2015 · Sonja Postma, Evelien Kolkman, et al. · European Heart Journal Acute Cardiovascular Care · 14
The influence of system delay on 30-day and on long-term mortality in patients with anterior versus non-anterior ST-segment elevation myocardial infarction: a cohort study
2015 · Sonja Postma, Jan-Henk E Dambrink, et al. · Open Heart · 13
PDF
Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel
2008 · Sonja Postma, Johannes Kelder, et al. · Thrombosis and Haemostasis · 12
Short‐term dual antiplatelet therapy in diabetic patients admitted for acute coronary syndrome treated with a new‐generation drug‐eluting stent
2022 · Nousjka P. A. Vranken, Saman Rasoul, et al. · Diabetes/Metabolism Research and Reviews · 10
Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial
2021 · Elvin Kedhi, Monica Verdoia, et al. · Atherosclerosis · 10
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: The transcatheter valve and vessels trial (TCW trial): Design and rationale
2024 · Elvin Kedhi, Andi Rroku, et al. · American Heart Journal · 8
PDF
Early ambulance initiation versus in-hospital initiation of high dose clopidogrel in ST-segment elevation myocardial infarction
2014 · Sonja Postma, Jan-Henk Dambrink, et al. · Thrombosis and Haemostasis · 8
Pre-hospital diagnosis, triage and treatment in patients with ST elevation myocardial infarction
2012 · Sonja Postma, Thomas Bergmeijer, et al. · Heart · 6
Prehospital Treatment of ST-segment Elevated Myocardial Infarction Patients
2013 · Thomas O Bergmeijer, Sonja Postma, et al. · Future Cardiology · 5
Beta-blocker effect on ST-segment: a prespecified analysis of the EARLY-BAMI randomised trial
2020 · Enrico Fabris, Renicus Hermanides, et al. · Open Heart · 4
PDF
The extent of ST elevation and ST deviation as predictors of mortality in ST-segment elevation myocardial patients planned to undergo primary percutaneous coronary intervention
2015 · S. Postma, J.H.E. Dambrink, et al. · International Journal of Cardiology · 4
Predictive Value of Various Platelet Function Tests on St-segment Resolution and Clinical Outcome in Stemi Patients Randomized to Either Dual or Triple Antiplatelet Therapy: the Ontime2 Platelet Function Substudy
2010 · Heleen J. Bouman, Jochem W. van Werkum, et al. · Journal of the American College of Cardiology · 3
The novel subcutaneously administered glycoprotein IIb/IIIa antagonist RUC-4 (Zalunfiban) did not cause thrombocytopenia in the phase 2a study of patients with ST-elevation myocardial infarction
2022 · AOF Rikken, WL Bor, et al. · European Heart Journal Acute Cardiovascular Care · 1
PDF
Works count: 32
Citation count: 781
H-index: 13
I10-index: 17
Year
Topic
Type